STOCK TITAN
  1. Home
  2. Sec-filings
  3. AEON
  4. [EFFECT] AEON Biopharma, Inc. SEC Filing

[EFFECT] AEON Biopharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 17, 2026 5:30 P.M.
Form: S-3
CIK: 0001837607
Company Name: AEON Biopharma, Inc.
File Number: 333-293309

Source: View Original Filing on SEC EDGAR

Stock AEON logo
Aeon Biopharma

NYSE:AEON

AEON Rankings

#5891 Ranked by Market Cap
N/A Ranked by Dividends

AEON Latest News

Jan 21, 2026
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
Dec 19, 2025
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Dec 15, 2025
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
Nov 20, 2025
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
Nov 14, 2025
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

AEON Latest SEC Filings

Feb 19, 2026
[Form 4] AEON Biopharma, Inc. Insider Trading Activity
Feb 18, 2026
[424B3] AEON Biopharma, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 9, 2026
[S-3] AEON Biopharma, Inc. Shelf Registration Statement
Jan 29, 2026
[Form 3] AEON Biopharma, Inc. Initial Statement of Beneficial Ownership
Jan 29, 2026
[SCHEDULE 13D] AEON Biopharma, Inc. Major Shareholder Acquisition (>5%)

AEON Stock Data

30.36M
10.43M
Biotechnology
Pharmaceutical Preparations
Link
United States
IRVINE